Memphasys Ltd (AU:MEM) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Memphasys Limited (ASX: MEM), a leader in reproductive biotechnology, announced the successful outcomes of its 2024 Annual General Meeting. Key resolutions, including the election and re-election of directors and the approval of strategic mandates, were carried with strong support. This marks a positive step for the company as it continues to innovate in biotechnology applications.
For further insights into AU:MEM stock, check out TipRanks’ Stock Analysis page.
